Nonseminomatous Germ Cell Tumor
📧 Sign up to get email alerts when something new happens for Nonseminomatous Germ Cell Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors [Phase 2]
Phase 2 clinical trial evaluating the combination of durvalumab and tremelimumab for relapsed/refractory germ cell tumors; the study is curr…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: CD30 CAR for CD30+ NSGCT [Phase 2]
Phase 2 clinical trial evaluating CD30-targeted CAR-T cell therapy for CD30-positive nonseminomatous germ cell tumors has completed.
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Robot-assisted ICG-guided Sentinel Node Biopsy in Testicular Cancer [NA]
This is an update on a clinical trial evaluating robot-assisted, indocyanine green (ICG)-guided sentinel node biopsy for testicular cancer, …
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors [Phase 2]
Phase 2 trial of brentuximab vedotin in relapsed/refractory germ cell tumors was terminated; results posted in 2019.